Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Dubromel A"'
Autor:
Clement, Benoit, Dubromel, Marie, Santos, Paulo E., Sammut, Karl, Oppert, Michelle, Dayoub, Feras
Autonomous vessels have emerged as a prominent and accepted solution, particularly in the naval defence sector. However, achieving full autonomy for marine vessels demands the development of robust and reliable control and guidance systems that can h
Externí odkaz:
http://arxiv.org/abs/2404.11882
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
BackgroundDiabetes affects millions of people worldwide, making them more vulnerable to infections, including seasonal influenza. It is therefore particularly important for those suffering from diabetes to be vaccinated against influenza each year. H
Externí odkaz:
https://doaj.org/article/553d74fa826f49c987dae5c2561a4d7e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Karen Beny, Amélie Dubromel, Benjamin du Sartz de Vigneulles, Valérie Gay, Florence Carrouel, Claude Negrier, Claude Dussart
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
Background Several innovative drugs liable to lead to changes in healthcare organization are or soon will be available for the management of hemophilia. Analyzing their implementation can shed further light on healthcare decision-making, to anticipat
Externí odkaz:
https://doaj.org/article/0f1818805d7844fa81d119a4624b4fc5
Autor:
Beny, Karen1,2 (AUTHOR) karen.beny@chu-lyon.fr, Dubromel, Amélie2 (AUTHOR), du Sartz de Vigneulles, Benjamin1 (AUTHOR), Gay, Valérie3 (AUTHOR), Carrouel, Florence1 (AUTHOR), Negrier, Claude4 (AUTHOR), Dussart, Claude1,2 (AUTHOR)
Publikováno v:
PLoS ONE. 9/9/2022, Vol. 17 Issue 9, p1-14. 14p.
Publikováno v:
Journal of Market Access & Health Policy, Vol 8, Iss 1 (2020)
Background Organizational aspect is rarely considered in healthcare. However, it is gradually seen as one of the key aspects of the decision-making process as well as clinical and economic dimensions. Our primary objective was to identify criteria al
Externí odkaz:
https://doaj.org/article/544176fe5b174c99bbd613538d773482
Autor:
Baudouin, Amandine, Fargier, Emilie, Cerruti, Ariane, Dubromel, Amélie, Vantard, Nicolas, Ranchon, Florence, Schwiertz, Vérane, Salles, Gilles, Souquet, Pierre-Jean, Thomas, Luc, Bérard, Frédéric, Nancey, Stéphane, Freyer, Gilles, Trillet-Lenoir, Véronique, Rioufol, Catherine
Publikováno v:
In Bulletin du Cancer June 2017 104(6):538-551
Publikováno v:
IFAC-PapersOnLine; January 2024, Vol. 58 Issue: 20 p147-152, 6p
Publikováno v:
Journal of Market Access & Health Policy, Vol 6, Iss 1 (2018)
Background: In France, a significant part of health expenditure is publicly funding. This put a heavy burden on society. In an economic context requiring tight control of public spending, it seems relevant to control the diffusion of medical innovati
Externí odkaz:
https://doaj.org/article/3cbc0728012147138df2f78dd5cc7870
Autor:
Amélie Dubromel, Chloé Herledan, Pauline Pralong, Florence Ranchon, Nicolas Vantard, Virginie Larbre, Jean-François Nicolas, F. Hacard, Catherine Rioufol, Audrey Nosbaum, Frédéric Bérard, Amandine Baudouin, Anne-Gaëlle Caffin, Vérane Schwiertz
Publikováno v:
Journal of Oncology Pharmacy Practice. 28:1552-1559
Background Cancer patients are being exposed to antineoplastic drugs more frequently and for longer periods, resulting in a higher risk of hypersensitivity reactions. The aim of this study was to assess the pharmaceutical time and direct cost of drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e08ffc29f83e2cb592504576e8e7b9e
https://doi.org/10.1177/10781552211035695
https://doi.org/10.1177/10781552211035695